Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Multicentre, Open-Label, Parallel-Group, Randomised, Controlled, Phase 3 Trial
Lancet 2021 Jun 04;[EPub Ahead of Print], YP Chen, X Liu, Q Zhou, KY Yang, F Jin, XD Zhu, M Shi, GQ Hu, WH Hu, Y Sun, HF Wu, H Wu, Q Lin, H Wang, Y Tian, N Zhang, XC Wang, LF Shen, ZZ Liu, J Huang, XL Luo, L Li, J Zang, Q Mei, BM Zheng, D Yue, J Xu, SG Wu, YX Shi, YP Mao, L Chen, WF Li, GQ Zhou, R Sun, R Guo, Y Zhang, C Xu, JW Lv, Y Guo, HX Feng, LL Tang, FY Xie, Y Sun, J MaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.